Type 2 diabetes mellitus (T2DM) is associated with poorer performance on certain measures of cognitive function. However, little is known about the associations among working memory (WM), executive function (EF), and self-care in those with severe T2DM. This investigation explored these relationships among 67 middle-aged and older individuals with T2DM (mean age of 62.9 years). Severity of T2DM was measured with a health status composite (HSC) score from the Diabetes Care Profile, the number of prescribed medications, and the number of comorbid conditions. Cognitive assessments included the Working Memory Index and the Executive Interview 25 (EXIT 25). Self-care was measured using the Self-Care Inventory–Revised (SCI-R) and hemoglobin A1c (HgbA1c). WM was significantly correlated with all measures of severity of T2DM (HSC, r = .542, p < . 01; number of comorbidities, r = −.476, p < .01; and number of prescription medications, r = −.344, p < .01). EF was significantly correlated with all measures of severity of T2DM (HSC, r = −.504, p < .01; number of comorbidities, r = .492, p < .01; and number of prescription medications, r = .326, p < .01). The self-care measure HgbA1c was significantly correlated with WM (r = −.352, p < .01) and EF (r = .510, p < .01). The EXIT 25 score fully mediated the relationship between severity of T2DM and self-care as measured by HgbA1c (β = .431, p < .001). These findings provide preliminary evidence for the associations among severity of T2DM, WM, EF, and self-care.
AllenK. V.FrierB. M.StrachanM. W. (2004). The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations. European Journal of Pharmacology, 490, 169–175.
2.
American Diabetes Association. (2013). Standards of medical care in diabetes—2013. Diabetes Care, 36, S11–S66.
3.
ArvanitakisZ.WilsonR. S.BieniasJ. L.BennettD. A. (2006). Diabetes mellitus, dementia, and cognitive function in older persons. Journal of Nutrition, Health and Aging, 10, 287–291.
4.
AsimakopoulouK.HampsonS.MorrishN. (2002). Neuropsychological functioning in older people with type 2 diabetes: The effect of controlling for confounding factors. Diabetic Medicine, 19, 311–316.
5.
AwadN.GagnonM.MessierC. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical Experimental Neuropsychology, 26, 1044–1080.
6.
BaronR. M.KennyD. A., (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.
7.
BiesselsG.ter BraakE.ErkelensD.HijmanR., (2002). Cognitive function in patients with type 2 diabetes mellitus. Neuroscience Research Communications, 28, 11–22.
8.
BruceJ. M.HarringtonC. J.FosterS.WesterveltH. J. (2009). Common blood laboratory values are associated with cognition among older inpatients referred for neuropsychological testing. Clinical Neuropsychologist, 23, 909–925.
9.
BruehlH.WolfO. T.SweatV.TirsiA.RichardsonS.ConvitA. (2009). Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Research, 1280, 186–194.
10.
Centers for Disease Control and Prevention. (2011) National diabetes fact sheet: General information and national estimates on diabetes in the United States. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
11.
ChungS.HoE.LamK.ChungS. (2003). Contribution of polyol pathways to diabetes induced oxidative stress. Journal of the American Society of Nephrology, 14, 233–236.
12.
CoxD. J.KovatchevB. P.Gonder-FrederickL. A.SummersK. H.McCallA.GrimmK. J.WilliamL. C. (2005). Relationship between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care, 28, 71–77.
13.
CukiermanT.GersteinH. C.WilliamsonJ. D. (2005). Cognitive decline and dementia in diabetes: Systematic overview of prospective observational studies. Diabetologia, 48, 2450–2469.
14.
CunninghamV.MohlerM. J.WendelC. S.HoffmanR. M.MurataG. H.ShahJ. H.DuckworthW. C. (2005). Reliability and validity of the DCP among Hispanic veterans. Evaluation and the Health Profession, 28, 447–463.
15.
de WetH.LevittN.TippingB., (2007). Executive cognitive impairment detected by simple bedside testing is associated with poor glycaemic control in type 2 diabetes. South African Medical Journal, 97, 1074–1076.
16.
EngleR. W.TuholskiS. W.LaughlinJ. E.ConwayA. R. (1999). Working memory, short term memory, and general fluid intelligence: A latent-variable approach. Journal of Experimental Psychology, 128, 309–331.
17.
FitzgeraldJ. T.AndersonR. M.GruppenL. D.DavisW. K.AmanL. C.JacoberS. J.GrunbergerG. (1998). The reliability of the Diabetes Care Profile for African Americans. Evaluation and the Health Professions, 21, 52–55.
18.
FitzgeraldJ. T.DavisW. K.ConnellC. M.HessG. E.FunnellM. M.HissR. G. (1996) Development and validation of the diabetes care profile. Evaluation & the Health Professions, 19, 208–230.
19.
FolsteinM. F.FolsteinS. E.McHughP. R, (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
20.
GoldS. M.DziobekI.SweatV.TirsiA.RogersK.BruehlH.ConvitA. M. (2007). Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia, 50, 711–719.
21.
HuangC. Q.WangZ. R.LiY. H.XieY. Z.LiuQ. X. (2011). Cognitive function and risk for depression in old age: A meta-analysis of published literature. International Psychogeriatrics, 23, 516–525.
22.
InselK.MorrowD.BrewerB.FigueredoA. (2006). Executive function, working memory, and medication adherence among older adults. Journals of Gerontology Series B-Psychological Sciences & Social Sciences, 61, 102–107.
23.
JorgensenT.JohanssonS.KennerfalkA.WallanderM.SvardsuddK. (2001). Prescription drug use, diagnoses, and healthcare utilization among the elderly. Annals of Pharmacotherapy, 35,1004–1009.
24.
KaneM. J.EngleR. W. (2003). Working memory capacity and the control of attention: The contribution of goal neglect, response competition, and task set to Stroop interference. Journal of Experimental Psychology, 132, 47–70.
25.
KorfE. S.WhiteL. R.ScheltensP.LaunerL. J. (2006). Brain aging in very old men with type 2 diabetes: The Honolulu-Asia aging study. Diabetes Care, 29, 2268–2274.
26.
LarsonE.HeinemannA. (2010). Rasch analysis of the Executive Interview (the EXIT -25) and introduction of an abridged version (the Quick EXIT). Archives of Physical Medicine and Rehabilitation, 91, 389–394.
27.
LarsonE.LeahyB.DuffK.WildeM. (2008). Assessing executive functions in traumatic brain injury: An exploratory study of the executive interview. Perceptual and Motor Skills, 106, 725–736.
28.
MonsellS. (2003). Task switching. Trends in Cognitive Sciences, 7, 134–140.
29.
McCabeD.RoedigerH.McDanielM.BalotaD.HambrickD. (2010). The relationship between working memory capacity and executive functioning: Evidence for a common executive attention construct. Neuropsychology, 24, 222–243.
30.
McDermottL. M.EbmeierK. P. (2009). A meta-analysis of depression severity and cognitive function. Journal of Affective Disorders, 119, 1–8.
31.
NooyensA.BaanC.SpijkermanA.VerschurenW. (2010). Type 2 diabetes and cognitive decline in middle-age men and women. Diabetes Care, 33, 1964–1968.
32.
OkerekeO.HankinsonS.HuF.GrodsteinF. (2005). Plasma C peptide level and cognitive function among older women without diabetes mellitus. Archives of Internal Medicine, 165, 1651–1656.
33.
PeyrotM.RubinR. R.LauritzenT.SnoekF. J.MatthewsD. R.SkovlundS. E. (2005). Psychosocial problems and barriers to improved diabetes management: Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabetic Medicine, 22, 1379–1385.
34.
Psychological Corporation. (1997). WAIS-III/WMS-III technical manual. San Antonio, TX: Author.
35.
QiuW. Q. Q.PriceL. L.HibberdP.BuellJ.CollinsL.LeinsD.FolsteinM. (2006). Executive dysfunction in homebound older people with diabetes mellitus. Journal of the American Geriatric Society, 54, 496–501.
36.
RadloffL. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
37.
RamasamyR.VannucciS.YanS. H.HeroldK.YanS.SchmidtA. (2005). Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology, 15, 16–28.
38.
RiglerS.PereraS.JachnaC.ShiremanT.EngM. (2004). Comparison of the association between disease burden and inappropriate medication use across three cohorts of older adults. American Journal of Geriatric Pharmacotherapy, 2, 239–247.
39.
RobertsR.GedaY.KnopmanD.ChristiansonT.PankratzV.BoeveB.PetersenR. (2008). Association of duration of severity of diabetes mellitus with mild cognitive impairment. Archives of Neurology, 65, 1066–1073.
40.
Roriz-FilhoJ. S.Sa-RorizT. M.RossetI.CamozzatoA. L.SantosA. C.ChavesM. L.Roriz-CruzM. R. (2009). Diabetes, brain aging, and cognition. Biochimica et Biophysica Acta, 1792, 432–443.
41.
RoyallD.MahurinR.CornellJ. (1994). Bedside assessment of frontal degeneration: Distinguishing Alzheimer’s disease from non-Alzheimer’s cortical dementia. Experimental Aging Research, 20, 95–103.
42.
RoyallD.MahurinR.GrayK. (1992) Bedside assessment of the executive cognitive impairment: The executive interview. Journal of the American Geriatric Society, 40, 1221–1226.
43.
SacksD. B.BrunsD. E.GoldsteinD. E.MaclarenN. K.McDonaldJ. M.ParrottM., (2002). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry, 48, 436–472.
44.
SaczynskiJ. S.JonsdottirM. K.GarciaM. E.JonssonP. V.PeilaR.EiriksdottirG.LaunerL. (2008). Cognitive impairment: An increasingly important complication of type 2 diabetes: The age, gene/environment susceptibility—Reykjavik study. American Journal of Epidemiology, 168, 1132–1139.
45.
SimaA.KamiyaH.LiZ. (2004). Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. European Journal of Pharmacology, 490, 187–197.
46.
SinclairA.GirlingA.BayerA., (2000). Cognitive dysfunction in older subjects with diabetes mellitus: Impact on diabetes self-management and use of care services. Diabetes Research and Clinical Practice, 50, 203–212.
47.
SpauwenP.KohlerS.VerheyF.StehouwerC.van BoxtelM. (2013). Effects of type 2 diabetes on 12-year cognitive change. Diabetes Care, 36, 1554–1561.
48.
StahlD.SumC. F.LumS. S.LiowP. H.ChanY. H.VermaS.ChongS. A. (2008). Validation of the Center for Epidemiologic Studies Depression Scale (CES-D) in a multiethnic group of patients with diabetes in Singapore. Diabetes Care, 31, 1118–1119.
49.
StokholmJ.VogelA.GadeA.WaldemarG. (2005). The executive interview as a screening test for executive dysfunction in patients with mild dementia. Journal of the American Geriatrics Society, 53, 1577–1581.
50.
TanK.ChowW.AiV.MetzC.BucalaR.LamK., (2002). Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care, 25, 1055–1059.
51.
ThabitH.KennellyS. M.BhagarvaA.OgunleweM.McCormickP. M. E.McDermottJ. H.SreenanS. (2009). Utilization of frontal assessment battery and executive interview 25 in assessing for dysexecutive syndrome and its association with diabetes self-care in elderly patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 86, 208–212.
52.
TolijamoM.HentinenM. (2001). Adherence to self-care and social support. Journal of Clinical Nursing, 10, 618–628.
53.
TombaughT. N.McIntyreN. J., (1992). The mini-mental state examination: A comprehensive review. Journal of the American Geriatrics Society, 40, 922–935.
54.
WatsonG.CraftS. (2006). Insulin resistance, inflammation, and cognition in Alzheimer’s disease: Lessons for multiple sclerosis. Journal of the Neurological Sciences, 245, 21–33.
55.
WeingerK.ButlerH.WelchG.LaGrecaA. (2005). Measuring diabetes self-care: A psychometric analysis of the Self-care Inventory-revised with adults. Diabetes Care, 28, 1346–1352.
